Published in Hepatitis Weekly, May 6th, 1996
Although the efficacy of interferon treatment has been well documented in adults with chronic hepatitis B disease, the results in children are less conclusive because most clinical trials have included a small number of patients. In addition, the interpretation of the data is complicated by variations in interferon dose schedules, disparities in patient characteristics in terms of disease activity, or mode of infection and differences in rates of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.